← Every company
Emergent BioSolutions Inc Planned Sales
Before an insider at Emergent BioSolutions Inc can sell restricted stock they have to file notice of it. This is that notice — the leading edge of the insider trading feed, filed days before the sale it describes.
EBS insider trades →Notices on file
1
Insiders
1
Shares noticed
17.8K
permission to sell, not sales
Estimated value
$126.1K
as estimated on filing
Largest notices first
Value is the filer's own estimate of what the sale would raise, at the time they filed.
| Seller | Est. value |
|---|---|
| Degolyer DonaldDirector2026-10-0717.8K sh0.03% | $126.1K |
Source: SEC Form 144 notices, via EDGAR. A notice is permission to sell, not a completed sale — it is often used only in part, or not at all, so none of this is volume and none of it should be added to the insider trading feed. Value is the filer's estimate on the day they filed.
More on EBS
Company overviewEverything on EBS in one place, with the price.SEC filingsWhat EBS's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat EBS's own officers and directors buy and sell.Who owns itEvery manager reporting a position in EBS.Funds holding itWhich funds and ETFs hold EBS, and how big a bet.LobbyingWhat EBS spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on EBS's account, and who they worked for.Federal contractsWhat federal agencies pay EBS.